Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 5:36 p.m.

    🌍 Galapagos NV (GLPG) - Form 6-K Filing

    Filing Date: 2022-06-23

    Accepted: 2022-06-23 11:21:40

    Event Type: Clinical Trial Update

    Event Details:

    Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies. Potential for paradigm shift in CAR-T therapy with CellPoints decentralized point-of-care manufacturing model, in partnership with Lonza. AboundBios cutting-edge fully human antibody-based capabilities.

    💼 Business Developments:

    • ✅ Partnership/Collaboration
    • ✅ Acquisition Activity
    • ❌ Licensing Agreement: Not reported
    • ✅ Regulatory Milestone
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Email: 63ir@glpg.com

Search

News categories